Velan Capital Investment Management’s Cidara Therapeutics CDTX Stock Holding History

Velan Capital Investment Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-108,404	Closed	-$23.9M	–	50
2025 Q4	$23.9M	Hold	108,404	–	–	13.89%	2
2025 Q3	$10.4M	Buy	108,404 +8,404	+8%	+$536K	9.75%	2
2025 Q2	$4.87M	Buy	+100,000	New	+$2.4M	4.81%	8

Velan Capital Investment Management's CDTX Position: Q1 2026 in Review

Velan Capital Investment Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 108,404 shares — an estimated $23.9M sold.

Velan Capital Investment Management first reported a position in CDTX in Q2 2025 and held it in 3 quarters. The position peaked at $23.9M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Velan Capital Investment Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Velan Capital Investment Management sold 108,404 Cidara Therapeutics shares in Q1 2026, an estimated $23.9M.
Velan Capital Investment Management first reported a position in Cidara Therapeutics in Q2 2025 and held it in 3 quarters.
Velan Capital Investment Management's Cidara Therapeutics position peaked at $23.9M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.